Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2017.04.28
独立董事候选人声明（哈继铭）
2017.04.28
独立董事候选人声明（张荣庆）
2017.04.28
2016年度监事会工作报告
2017.04.28
独立董事候选人声明（陈俊发）
2017.04.28
关于公司控股股东及其他关联方资金占用情况汇总表的专项审核报告
2017.04.28
2016年度财务决算报告
2017.04.28
关于举行2016年度报告网上说明会的公告
2017.04.28
重大事项停牌公告
2017.04.28
关于公司募集资金年度存放与实际使用情况的鉴证报告
2017.04.28
2016年年度审计报告
第一页
上一页
80
81
82
83
84
下一页
最后一页
